1 / 1
MOTS-C, short for Mitochondrial Open Reading Frame of the 12S rRNA-c, is a mitochondria-derived bioactive peptide that has attracted growing attention in recent years within the fields of metabolism, exercise physiology, and aging research. Unlike most peptides and proteins in human biology, which are encoded by nuclear DNA, MOTS-C is encoded by the mitochondrial genome. This discovery has significantly expanded the traditional view of mitochondria, highlighting their role not only as cellular powerhouses but also as active signaling organelles capable of influencing cellular and systemic physiology.
From a biological perspective, MOTS-C functions as a key mediator of mitochondrial-to-nuclear communication. Under conditions of metabolic stress, nutrient fluctuation, or physical activity, MOTS-C expression and activity appear to increase, allowing it to participate in the regulation of cellular energy balance. Experimental studies suggest that MOTS-C interacts with major energy-sensing pathways, including those involving AMPK and mTOR, thereby promoting more efficient utilization of glucose and lipids. Through these mechanisms, MOTS-C has been associated with improved insulin sensitivity, enhanced metabolic flexibility, and protection against metabolic dysfunction in various cellular and animal models.
At the whole-organism level, MOTS-C is often described as an exercise-responsive signaling molecule. Circulating levels of MOTS-C have been shown to rise in response to physical activity, and its presence is thought to contribute to some of the metabolic adaptations typically induced by exercise, such as improved energy efficiency and endurance capacity. This has led to interest in MOTS-C as a potential “exercise-mimetic” factor, particularly in research contexts involving individuals or models with limited capacity for physical activity. However, these observations remain largely experimental, and their translational relevance to human health requires further investigation.
MOTS-C has also been linked to cellular stress responses and aging-related processes. Several studies indicate that it may enhance cellular resilience to oxidative stress and metabolic challenges, suggesting a possible role in maintaining cellular homeostasis over time. This has positioned MOTS-C as a molecule of interest in the broader study of healthy aging and age-associated metabolic decline. Nonetheless, findings across different experimental systems are not always consistent, underscoring the complexity of mitochondrial signaling and the need for more rigorous, standardized research.
In summary, MOTS-C represents a compelling example of how mitochondria can directly influence cellular and systemic regulation through peptide signaling. While preclinical studies highlight its potential involvement in metabolic regulation, exercise adaptation, and stress resilience, current evidence is primarily derived from in vitro and animal research. Critical questions regarding its long-term safety, physiological relevance, and therapeutic potential in humans remain unanswered. As such, MOTS-C is best regarded at present as an important research molecule and a promising biological target, rather than a clinically established intervention.
